0001225208-22-008089.txt : 20220614
0001225208-22-008089.hdr.sgml : 20220614
20220614182839
ACCESSION NUMBER: 0001225208-22-008089
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220610
FILED AS OF DATE: 20220614
DATE AS OF CHANGE: 20220614
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Wengel Kathryn E
CENTRAL INDEX KEY: 0001745955
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-03215
FILM NUMBER: 221016120
MAIL ADDRESS:
STREET 1: JOHNSON & JOHNSON
STREET 2: ONE JOHNSON & JOHNSON PLAZA
CITY: NEW BRUNSWICK
STATE: NJ
ZIP: 08933
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: JOHNSON & JOHNSON
CENTRAL INDEX KEY: 0000200406
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 221024240
STATE OF INCORPORATION: NJ
FISCAL YEAR END: 0101
BUSINESS ADDRESS:
STREET 1: ONE JOHNSON & JOHNSON PLZ
CITY: NEW BRUNSWICK
STATE: NJ
ZIP: 08933
BUSINESS PHONE: 732-524-2455
MAIL ADDRESS:
STREET 1: ONE JOHNSON & JOHNSON PLZ
CITY: NEW BRUNSWICK
STATE: NJ
ZIP: 08933
4
1
doc4.xml
X0306
4
2022-06-10
0000200406
JOHNSON & JOHNSON
JNJ
0001745955
Wengel Kathryn E
ONE JOHNSON & JOHNSON PLAZA
NEW BRUNSWICK
NJ
08933
1
EVP, Chief GSC Officer
Common Stock
2022-06-10
4
M
0
40000.0000
72.5400
A
111310.8735
D
Common Stock
2022-06-10
4
S
0
100.0000
173.0010
D
111210.8735
D
Common Stock
2022-06-10
4
S
0
174.0000
173.0010
D
111036.8735
D
Common Stock
2022-06-10
4
S
0
6600.0000
173.0010
D
104436.8735
D
Common Stock
2022-06-10
4
S
0
33126.0000
173.0010
D
71310.8735
D
Common Stock
50.0000
I
By 401k
Common Stock
281.0000
I
By ESOP
Employee Stock Options (Right to Buy)
72.5400
2022-06-10
4
M
0
40000.0000
0.0000
D
2016-01-17
2023-01-13
Common Stock
40000.0000
16410.0000
D
This transaction was executed in multiple trades at prices ranging from 173.00 to 173.02 . The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide, upon request, to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Includes shares accrued due to dividend reinvestment in the Johnson & Johnson Stock Fund under the Johnson & Johnson Savings Plan as of the Plan's most recent reporting date (5/31/2022)
Shares held by ESOP under the Johnson & Johnson Savings Plan as of the Plan's most recent reporting date (5/31/2022)
Raavi K. Deol, as attorney-in-fact for Kathryn E. Wengel
2022-06-14